NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in NovaBridge Biosciences as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q3 2024
- Shares held
- 11.9M
- −2.28M (−16.1%) vs. Q3 2024
- Total value
- $10.1M
- −$7.48M (−42.5%) vs. Q3 2024
- New holders
- 7
- 3 more added
- Sold out
- 7
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 814 | $0 | 0.00% | +397+95.2% | Added |
| Citigroup Inc | 50 | $43 | 0.00% | 00.0% | Unchanged |
| Vermillion Wealth Management, Inc. | 200 | $170 | 0.00% | +200 | New |
| Bank of America Corp | 566 | $481 | 0.00% | −2−0.4% | Reduced |
| SBI Securities Co., Ltd. | 905 | $769 | 0.00% | +905 | New |
| Citadel Advisors LLC | 931 | $791 | 0.00% | −97,458−99.1% | Reduced |
| Legal & General Group Plc | 1,191 | $1.01K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,367 | $1.16K | 0.00% | 00.0% | Unchanged |
| Freestone Capital Holdings, LLC | 10,000 | $8.50K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 10,685 | $9.08K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 13,087 | $11.0K | 0.00% | +13,087 | New |
| Geode Capital Management, LLC | 22,037 | $18.7K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 28,760 | $24.4K | 0.00% | −2,775−8.8% | Reduced |
| Barclays PLC | 30,370 | $25.8K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 58,358 | $49.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 63,800 | $54.2K | 0.00% | 00.0% | Unchanged |
| Alberta Investment Management Corp | 74,723 | $63.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 97,749 | $83.1K | 0.00% | +86,424+763.1% | Added |
| UBS Group AG | 103,054 | $87.6K | 0.00% | +103,054 | New |
| BNP Paribas Arbitrage, SA | 109,209 | $92.8K | 0.00% | +109,209 | New |
| Cantor Fitzgerald, L. P. | 140,100 | $119.1K | 0.00% | +140,100 | New |
| Standard Life Aberdeen plc | 162,580 | $138.2K | 0.00% | 00.0% | Unchanged |
| EDBI Pte Ltd | 222,136 | $188.8K | 0.20% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 330,206 | $280.7K | 0.00% | −78,313−19.2% | Reduced |
| Two Sigma Advisers, LP | 430,800 | $366.2K | 0.00% | −68,500−13.7% | Reduced |
| SG Americas Securities, LLC | 475,862 | $404.0K | 0.00% | +475,862 | New |
| Morgan Stanley | 3,543,384 | $3.01M | 0.00% | +3,512,737+11,461.9% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 5,980,568 | $5.08M | 0.18% | −928,652−13.4% | Reduced |
| Caligan Partners LP | 0 | $0 | 0.00% | −3,499,330−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −1,419,080−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −566,650−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −43,039−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,351−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,015−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −1,438−100.0% | Sold out |